Plain-English translation of NCT06452914 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing semiconductor-embedded therapeutic socks as a treatment for diabetic neuropathy—nerve damage caused by diabetes that causes pain and numbness, especially in the feet. The socks are designed to emit infrared waves and negative ions that may increase blood circulation and reduce inflammation and pain. You would wear either the active therapeutic socks or regular socks (placebo) and report how you feel over time.
Diabetic nerve pain is a common and difficult problem, and current treatments focus mainly on blood sugar control and pain medication. This trial explores whether this treatment could offer a new, non-medication way to ease symptoms by improving blood flow and reducing inflammation in affected areas.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to wear either the special semiconductor-embedded therapeutic socks or regular socks as a comparison. You'll wear your assigned socks regularly and attend follow-up appointments where researchers will assess your pain level, circulation, and overall symptoms. The study involves clinical examinations to measure how well the treatment is working compared to the placebo socks.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States